Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

• Last SEC data release: 2026-04-30
• Last 15 days FTD volume: NZ$0.65 M
• Last 3 months FTD volume: NZ$5.07 M
• Last 12 months FTD volume: NZ$0.15 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	NZ$67.61 M	NZ$0.17 B	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$2.88 M	NZ$15.31 M	🇺🇸 USA
Cytokinetics CYTK	NZ$20.52 M	NZ$47.91 M	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$2.4 M	NZ$11.29 M	🇺🇸 USA
Palatin Technologies PTN	NZ$0.31 M	NZ$1.18 M	🇺🇸 USA
Eterna Therapeutics ERNA	N/A	NZ$0.02 M	🇺🇸 USA